Similarly, in MIA-induced osteoarthritis rat models, Rb1 (10 mg/kg) administration for 2 weeks improved joint histology, suppressed pro-inflammatory cytokines (e.g., IL-1β and IL-6), and enhanced chondrocyte viability. Here, IL1B is linked to osteoarthritis.